FENNEC PHARMACEUTICALS INC. Annual Selling and Marketing Expense in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2022 to 2023.
  • Fennec Pharmaceuticals Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $4.67M, a 99.7% increase year-over-year.
  • Fennec Pharmaceuticals Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $17.1M.
  • Fennec Pharmaceuticals Inc. annual Selling and Marketing Expense for 2023 was $12.1M, a 335% increase from 2022.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.1M +$9.34M +335% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.79M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.